Zidovudine (Edenbridge Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Zidovudine drug offered from Edenbridge Pharmaceuticals, LLC. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Edenbridge Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Zidovudine |
| SUBSTANCE NAME: | ZIDOVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-04-01 |
| END MARKETING DATE: | 0000-00-00 |
Zidovudine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zidovudine from Edenbridge Pharmaceuticals, LLC |
| LABELER NAME: | Edenbridge Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2012-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42799-403_c2002324-a271-4402-8f39-8cdbcfd61080 |
| PRODUCT NDC: | 42799-403 |
| APPLICATION NUMBER: | ANDA078349 |
Other ZIDOVUDINE Pharmaceutical Manufacturers / Labelers:
